Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionFirst PREMIER Bank
Latest Disclosed Ownership8,950 shares
Latest Disclosed Value $ 3,148
First PREMIER Bank reports 0.93% decrease in ownership of AMGN / Amgen Inc.

On April 20, 2026 - First PREMIER Bank filed a 13F-HR form disclosing ownership of 8,950 shares of Amgen Inc. (MX:AMGN) valued at $3,148 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 9,034 shares of Amgen Inc.. This represents a change in shares of -0.93% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F AMGEN COM 031162100 8,950 -84 -0.93 3 50.00 0.3533
2026-01-23 2025-12-31 13F AMGEN COM 031162100 9,034 -145 -1.58 3 0.00 0.6777
2025-10-15 2025-09-30 13F AMGEN COM 031162100 9,179 -70 -0.76 3 0.00 0.5881
2025-07-11 2025-06-30 13F AMGEN COM 031162100 9,249 -121 -1.29 3 0.00 0.6251
2025-04-22 2025-03-31 13F AMGEN COM 031162100 9,370 0 0.00 3 0.00 0.7408
2025-01-17 2024-12-31 13F AMGEN COM 031162100 9,370 -20 -0.21 2 -33.33 0.6219
2024-10-08 2024-09-30 13F AMGEN COM 031162100 9,390 -169 -1.77 3 50.00 0.7544
2024-07-17 2024-06-30 13F AMGEN COM 031162100 9,559 -55 -0.57 3 0.00 0.7990
2024-04-12 2024-03-31 13F AMGEN COM 031162100 9,614 -110 -1.13 3 0.00 0.7227
2024-01-17 2023-12-31 13F AMGEN COM 031162100 9,724 -98 -1.00 3 0.00 0.7852
2023-10-16 2023-09-30 13F AMGEN COM 031162100 9,822 -219 -2.18 3 0.00 0.8095
2023-07-13 2023-06-30 13F AMGEN COM 031162100 10,041 -250 -2.43 2 0.00 0.6368
2023-04-10 2023-03-31 13F AMGEN COM 031162100 10,291 -215 -2.05 2 0.00 0.7251
2023-01-17 2022-12-31 13F AMGEN COM 031162100 10,506 -37 -0.35 3 -99.92 0.8357
2022-10-20 2022-09-30 13F AMGEN COM 031162100 10,543 43 0.41 2,376 -7.01 0.7753
2022-07-26 2022-06-30 13F AMGEN COM 031162100 10,500 -30 -0.28 2,555 0.31 0.7627
2022-04-25 2022-03-31 13F AMGEN COM 031162100 10,530 200 1.94 2,547 9.60 0.6712
2022-01-19 2021-12-31 13F AMGEN COM 031162100 10,330 75 0.73 2,324 6.56 0.6015
2021-10-12 2021-09-30 13F AMGEN COM 031162100 10,255 0 0.00 2,181 -12.76 0.6182
2021-07-14 2021-06-30 13F AMGEN COM 031162100 10,255 626 6.50 2,500 4.38 0.7216
2021-04-12 2021-03-31 13F AMGEN COM 031162100 9,629 0 0.00 2,395 8.18 0.8482
2021-01-12 2020-12-31 13F AMGEN COM 031162100 9,629 -242 -2.45 2,214 -11.76 0.8780
2020-10-06 2020-09-30 13F AMGEN COM 031162100 9,871 0 0.00 2,509 7.77 1.1048
2020-07-07 2020-06-30 13F AMGEN COM 031162100 9,871 225 2.33 2,328 19.02 1.1207
2020-04-08 2020-03-31 13F AMGEN COM 031162100 9,646 26 0.27 1,956 -15.65 1.0899
2020-01-10 2019-12-31 13F AMGEN COM 031162100 9,620 0 0.00 2,319 24.54 1.0843
2019-10-10 2019-09-30 13F AMGEN COM 031162100 9,620 110 1.16 1,862 6.28 0.9677
2019-07-09 2019-06-30 13F AMGEN COM 031162100 9,510 0 0.00 1,752 -2.99 0.9577
2019-04-04 2019-03-31 13F AMGEN COM 031162100 9,510 -60 -0.63 1,806 -3.06 1.0396
2019-01-14 2018-12-31 13F AMGEN COM 031162100 9,570 119 1.26 1,863 -4.85 1.2029
2018-10-09 2018-09-30 13F AMGEN COM 031162100 9,451 104 1.11 1,958 13.44 1.2088
2018-07-10 2018-06-30 13F AMGEN COM 031162100 9,347 860 10.13 1,726 19.28 1.1595
2018-04-09 2018-03-31 13F AMGEN COM 031162100 8,487 45 0.53 1,447 -1.50 1.0629
2018-01-11 2017-12-31 13F AMGEN COM 031162100 8,442 -443 -4.99 1,469 -11.35 1.0097
2017-10-13 2017-09-30 13F AMGEN COM 031162100 8,885 143 1.64 1,657 10.03 1.1584
2017-07-06 2017-06-30 13F AMGEN COM 031162100 8,742 460 5.55 1,506 10.82 1.1320
2017-04-12 2017-03-31 13F AMGEN COM 031162100 8,282 3,152 61.44 1,359 81.20 1.0312
2017-01-10 2016-12-31 13F AMGEN COM 031162100 5,130 1,637 46.87 750 28.64 0.5727
2016-10-13 2016-09-30 13F AMGEN COM 031162100 3,493 3,493 583 0.4395
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.